All Research Articles

61-80 of 800 ARTICLES
https://doi.org/10.12688/f1000research.129923.2
Research Article metrics
Revised
Brain-localized CD4 and CD8 T cells perform correlated random walks and not Levy walks
[version 2; peer review: 3 approved]
Peer Reviewers Rob De Boer; Masato S. Abe; Jens Stein
  • Funder
  • National Institutes of Health
LATEST VERSION PUBLISHED 03 Oct 2023
https://doi.org/10.12688/f1000research.139488.1
Software Tool Article metrics
Scalable and versatile container-based pipelines for de novo genome assembly and bacterial annotation.
[version 1; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Abdolrahman Khezri; Abhinav Sharma and Emilyn Costa Conceição; Austin G Davis-Richardson
  • Funders
  • Scholarship by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Grant by Fundação de Amparo à Pesquisa do Distrito Federal (FAP-DF)
PUBLISHED 25 Sep 2023
https://doi.org/10.12688/f1000research.130316.1
Research Article metrics
Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells
[version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Peer Reviewers Aamir Ahmed; Wenbin Zhou; Claudia Lanari and Andrés Elia
  • Funders
  • Al-Jalila Foundation
  • ASPIRE Precision Medicine Research Institute Abu Dhabi
PUBLISHED 08 Sep 2023
https://doi.org/10.12688/f1000research.132952.2
Data Note metrics
Revised
Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence
[version 2; peer review: 2 approved]
Peer Reviewers Nishant N Vaikath; Chi Kwan Tsang
  • Funders
  • Ontario Genomics
  • Canadian Institutes of Health Research Foundation
  • ALS Society of Canada
  • ALS Association
  • Motor Neurone Disease Association
  • Genome Quebec
  • Mitacs
  • Genome Canada
LATEST VERSION PUBLISHED 31 Aug 2023
https://doi.org/10.12688/f1000research.133203.1
Research Article metrics
An integrated RNA-proteomic landscape of drug induced senescence in a cancer cell line
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Ines Heiland; Kotb Abdelmohsen
  • Funders
  • European Union’s Horizon 2020 research and innovation programme (MESI-STRAT)
  • Trond Mohn Stiftelse
PUBLISHED 21 Aug 2023
https://doi.org/10.12688/f1000research.136998.3
Research Article metrics
Revised
The impact of shift-work light conditions on tissue-specific circadian rhythms of canonical clock genes: insights from a mouse model study
[version 3; peer review: 2 approved]
Peer Reviewers Tianpeng Zhang; Brian J. Altman
  • Funder
  • National Institutes of Health grant
LATEST VERSION PUBLISHED 17 Aug 2023
https://doi.org/10.12688/f1000research.126243.2
Review metrics
Revised
Integration of single-cell RNA sequencing and spatial transcriptomics to reveal the glioblastoma heterogeneity
[version 2; peer review: 3 approved]
Peer Reviewers Dieter Henrik Heiland; Theo Mantamadiotis; Georges Nemer
  • Funders
  • Fundacja na rzecz Nauki Polskiej
  • Narodowe Centrum Nauki
  • National Science Centre
LATEST VERSION PUBLISHED 09 Aug 2023
https://doi.org/10.12688/f1000research.129562.2
Research Article metrics
Revised
Enhanced human periodontal ligament stem cell viability and osteogenic differentiation on two implant materials: An experimental in vitro study
[version 2; peer review: 2 approved]
Peer Reviewers Samar Darwish; Sahar El Refai
  • Funder
  • Study was self funded
LATEST VERSION PUBLISHED 08 Aug 2023
https://doi.org/10.12688/f1000research.74506.3
Review metrics
Revised
Continued dysregulation of the B cell lineage promotes multiple sclerosis activity despite disease modifying therapies
[version 3; peer review: 2 approved]
Peer Reviewers Mickaël Bonnan; Maria Teresa Cencioni
LATEST VERSION PUBLISHED 01 Aug 2023
https://doi.org/10.12688/f1000research.139755.1
Data Note metrics
The identification of high-performing antibodies for Charged multivesicular body protein 2b for use in Western Blot, immunoprecipitation and immunofluorescence
[version 1; peer review: 2 approved]
Peer Reviewers Emma L. Clayton; Xiao-Xin Yan
  • Funders
  • Ontario Genomics
  • Canadian Institutes of Health Research Foundation
  • ALS Society of Canada
  • ALS Association
  • Motor Neurone Disease Association
  • Genome Quebec
  • Mitacs
  • Genome Canada
PUBLISHED 25 Jul 2023
https://doi.org/10.12688/f1000research.133852.1
Research Article metrics
Synergistic effect of the combination of Chrysanthemum cinerariifolium (Trev.) and doxorubicin in inhibiting PI3K and Cyclin D in oral squamous cell carcinoma: in vitro study
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Laiping Zhong
  • Funder
  • Ministry of Religion of the Republic of Indonesia
PUBLISHED 25 Jul 2023
https://doi.org/10.12688/f1000research.131861.2
Research Article metrics
Revised
Single-cell transcriptional uncertainty landscape of cell differentiation
[version 2; peer review: 2 approved]
Peer Reviewers Alessandro Giuliani; Geneviève Dupont
  • Funders
  • Swiss National Science Foundation
  • Agence Nationale de la Recherche
LATEST VERSION PUBLISHED 20 Jul 2023
https://doi.org/10.12688/f1000research.131852.2
Data Note metrics
Revised
The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence
[version 2; peer review: 2 approved]
Peer Reviewers Makoto Urushitani; Seiji Watanabe
  • Funders
  • Ontario Genomics
  • Canadian Institutes of Health Research Foundation
  • ALS Society of Canada
  • ALS Association
  • Motor Neurone Disease Association
  • Genome Quebec
  • Mitacs
  • Genome Canada
LATEST VERSION PUBLISHED 20 Jun 2023
https://doi.org/10.12688/f1000research.134023.1
Research Article metrics
Anti-inflammatory effects of oral cannabidiol in rat models
[version 1; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Marco Biagi; Gökhan Arslan
  • Funder
  • Thammasat University
PUBLISHED 15 Jun 2023
https://doi.org/10.12688/f1000research.133095.1
Research Article metrics
Association of PD-L1 immunoexpression with the clinicopathological characteristics and its prognostic significance in OPMD and OSCC: A cross-sectional study
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Simin Li; Baris Ertugrul
PUBLISHED 14 Jun 2023
https://doi.org/10.12688/f1000research.130883.1
Research Article metrics
Feasibility and guidelines for the use of an injectable fiducial marker (BioXmark®) to improve target delineation in preclinical radiotherapy studies using mouse models.
[version 1; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Emma Biglin; Jane Sosabowski and Rebecca Carter; Katrina Stevenson
  • Funder
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
PUBLISHED 22 May 2023
https://doi.org/10.12688/f1000research.121829.3
Research Article metrics
Revised
Integration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations
[version 3; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Tallulah Andrews; Xiang Chen
  • Funders
  • Wellcome
  • UK Research and Innovation
LATEST VERSION PUBLISHED 02 May 2023
https://doi.org/10.12688/f1000research.131414.1
Research Article metrics
Preserved correlation matrices pinpoint extracellular matrix organization as a critical factor in pancreatic ductal adenocarcinoma
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Stephan Joel Reshkin; Howard Crawford
  • Funder
  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
PUBLISHED 18 Apr 2023
https://doi.org/10.12688/f1000research.127234.2
Review metrics
Revised
Different levels of circadian (de)synchrony ­– where does it hurt?
[version 2; peer review: 2 approved]
Peer Reviewers Frank A.J.L. Scheer; Andrew N. Coogan
  • Funders
  • Deutscher Akademischer Austauschdienst
  • Deutsche Forschungsgemeinschaft
LATEST VERSION PUBLISHED 03 Apr 2023
https://doi.org/10.12688/f1000research.129250.3
Research Article metrics
Revised
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study
[version 3; peer review: 2 approved]
Peer Reviewers Swagat Ray; Poornima Rajendran
  • Funder
  • Indian Council of Medical Research
LATEST VERSION PUBLISHED 01 Mar 2023
61-80 of 800 ARTICLES
Articles
We publish a wide range of article types in science, engineering, medicine, social sciences and humanities, with no editorial biases.
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.